Epigenetic Reprogramming of Kaposi's Sarcoma-Associated Herpesvirus during Hypoxic Reactivation

被引:5
|
作者
Singh, Rajnish Kumar [1 ,2 ]
Bose, Dipayan [1 ]
Robertson, Erle S. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA
[2] Banaras Hindu Univ, Inst Med Sci, Mol Biol Unit, Varanasi 221005, Uttar Pradesh, India
基金
美国国家卫生研究院;
关键词
KSHV; hypoxia; epigenetic reprogramming; reactivation; LYTIC REPLICATION; LATENCY; ESTABLISHMENT; EXPRESSION; VIRUS; TRANSCRIPTION; HIF-1-ALPHA; LYMPHOMA;
D O I
10.3390/cancers14215396
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Epigenetic reprogramming of the KSHV genome plays a central role in lytic replication of Kaposi's sarcoma-associated herpesvirus (KSHV). Hypoxia, a common phenotype of cancer cells, exerts a negative effect on DNA replication. Interestingly, KSHV is known to bypass this repression and undergo lytic replication. Therefore, we investigated epigenetic reprogramming of the KSHV genome under hypoxic conditions. The KSHV genome was enriched with both transcriptional activator and repressor modifications of histones due to the upregulated expression of the modifying enzymes in KSHV-positive cells grown in hypoxia. KSHV-encoded antigens were responsible for this increase in modified histone proteins. The differential enrichment of KSHV-encoded LANA and RTA in hypoxia were suggestive of their role in transcriptional regulation. Furthermore, analysis investigating enrichment of DNA polymerase 1 alpha on the KSHV genome in conjunction with single molecule analysis of replicated DNA identified specific regions of the KSHV genome that may be critical for DNA replication in hypoxia. The biphasic life cycle (latent and lytic) of Kaposi's sarcoma-associated Herpesvirus (KSHV) is regulated by epigenetic modification of its genome and its associated histone proteins. The temporal events driving epigenetic reprogramming of the KSHV genome on initial infection to establish latency has been well studied, but the reversal of these epigenetic changes during lytic replication, especially under physiological conditions such as hypoxia, has not been explored. In this study, we investigated epigenetic reprogramming of the KSHV genome during hypoxic reactivation. Hypoxia induced extensive enrichment of both transcriptional activators and repressors on the KSHV genome through H3K4Me3, H3K9Me3, and H3K27Me3, as well as histone acetylation (H3Ac) modifications. In contrast to uniform quantitative enrichment with modified histones, a distinct pattern of RTA and LANA enrichment was observed on the KSHV genome. The enrichment of modified histone proteins was due to their overall higher expression levels, which was exclusively seen in KSHV-positive cells. Multiple KSHV-encoded factors such as LANA, RTA, and vGPCR are involved in the upregulation of these modified histones. Analysis of ChIP-sequencing for the initiator DNA polymerase (DNAPol1 alpha) combined with single molecule analysis of replicated DNA (SMARD) demonstrated the involvement of specific KSHV genomic regions that initiate replication in hypoxia.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus
    Hong Y.-K.
    Foreman K.
    Shin J.W.
    Hirakawa S.
    Curry C.L.
    Sage D.R.
    Libermann T.
    Dezube B.J.
    Fingeroth J.D.
    Detmar M.
    Nature Genetics, 2004, 36 (7) : 683 - 685
  • [32] Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency
    Bryan, BA
    Dyson, OF
    Akula, SM
    JOURNAL OF GENERAL VIROLOGY, 2006, 87 : 519 - 529
  • [33] A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation
    Ye, Fengchun
    Gao, Shou-Jiang
    CELL CYCLE, 2011, 10 (19) : 3237 - 3238
  • [34] Commentary: High Glucose Induces Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus
    Angius, Fabrizio
    Madeddu, Maria A.
    Pompei, Raffaello
    FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [35] Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
    Moore, PS
    Kingsley, LA
    Holmberg, SD
    Spira, T
    Gupta, P
    Hoover, DR
    Parry, JP
    Conley, LJ
    Jaffe, HW
    Chang, Y
    AIDS, 1996, 10 (02) : 175 - 180
  • [36] Vertical transmission of Kaposi's sarcoma-associated herpesvirus
    Mantina, H
    Kankasa, C
    Klaskala, W
    Brayfield, B
    Campbell, J
    Du, QJ
    Bhat, G
    Kasolo, F
    Mitchell, C
    Wood, C
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (05) : 749 - 752
  • [37] Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV)
    Chatlynne, LG
    Ablashi, DV
    SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) : 175 - 185
  • [38] Immune evasion by Kaposi's sarcoma-associated herpesvirus
    Coscoy, Laurent
    NATURE REVIEWS IMMUNOLOGY, 2007, 7 (05) : 391 - 401
  • [39] RNAs in the virion of Kaposi's sarcoma-associated herpesvirus
    Bechtel, J
    Grundhoff, A
    Ganem, D
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10138 - 10146
  • [40] Kaposi's sarcoma-associated herpesvirus and extracellular vesicles
    Barrett, Lindsey
    Dai, Lu
    Wang, Shanzhi
    Qin, Zhiqiang
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3294 - 3299